Sarah Frisch
About
After a bachelor’s degree in Applied Life Sciences Sarah Frisch studied Biotechnology at the UdS in Saarbrücken. Since 2020, she is a PhD student at the department of Drug Delivery (DDEL) at HIPS under Prof. Dr. Claus-Michael Lehr. She is part of the HIPS-UdS-TANDEM project and works on an in vitro model of the skin microbiome in destructive diseases of the hair follicle.
2022
Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties
Huck B, Murgia X, Frisch S, Hittinger M, Hidalgo A, Loretz B, Lehr C (2022)
Advanced Drug Delivery Reviews 183DOI: 10.1016/j.addr.2022.114141
2021
A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms
Frisch S, Boese A, Huck B, Horstmann J, Ho D, Schwarzkopf K, Murgia X, Loretz B, Souza Carvalho-Wodarz C, Lehr C (2021)
The Journal of antimicrobial chemotherapy 76 (6): 1472-1479DOI: 10.1093/jac/dkab068
2020
Synthesis and Biopharmaceutical Characterization of Amphiphilic Squalenyl Derivative Based Versatile Drug Delivery Platform
Ho D, Christmann R, Murgia X, Rossi C, Frisch S, Koch M, Schaefer U, Loretz B, Desmaele D, Couvreur P, Lehr C (2020)
Frontiers in chemistry 8DOI: 10.3389/fchem.2020.584242
2018
Farnesylated Glycol Chitosan as a Platform for Drug Delivery
Ho D, Frisch S, Biehl A, Terriac E, Rossi C, Schwarzkopf K, Lautenschläger F, Loretz B, Murgia X, Lehr C (2018)
Biomacromolecules 19 (8): 3489-3501DOI: 10.1021/acs.biomac.8b00795